CIK 0001750284 · Non-accelerated filer<br>Smaller reporting company
Olema Oncology, Inc.
Sign in to watch- Ticker
- OLMA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 300409740
- Phone
- (415) 651-3316
- Business address
- 365 OYSTER POINT BOULEVARD, SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- Olema Pharmaceuticals, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 17 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-09-27 | Bohen Sean PRESIDENT AND CEO | Option exercise · Stock Option (Right to Buy) | −1,085 | 971,316 | ||
| 2021-09-20 | Harmon Cyrus CHIEF TECHNOLOGY OFFICER | Sale | −12,000 | $26.30 | $316K | 1,063,546 |
| 2021-09-10 | Horn Kinney CHIEF BUSINESS OFFICER | Option exercise | +5,251 | $2.06 | $11K | 7,041 |
| 2021-09-10 | Horn Kinney CHIEF BUSINESS OFFICER | Sale | −5,251 | $29.38 | $154K | 1,790 |
| 2021-09-10 | Horn Kinney CHIEF BUSINESS OFFICER | Option exercise · Stock Option (Right to Buy) | −5,251 | 173,293 | ||
| 2021-09-08 | Bohen Sean PRESIDENT AND CEO | Option exercise | +2,631 | $4.82 | $13K | 56,905 |
| 2021-09-08 | Bohen Sean PRESIDENT AND CEO | Sale | −2,631 | $30.00 | $79K | 52,514 |
| 2021-09-08 | Bohen Sean PRESIDENT AND CEO | Option exercise · Stock Option (Right to Buy) | −2,631 | 972,401 | ||
| 2021-09-07 | Bohen Sean PRESIDENT AND CEO | Option exercise | +413 | $4.82 | $2K | 54,687 |
| 2021-09-07 | Bohen Sean PRESIDENT AND CEO | Sale | −413 | $30.08 | $12K | 54,274 |
| 2021-09-07 | Bohen Sean PRESIDENT AND CEO | Option exercise · Stock Option (Right to Buy) | −413 | 975,032 | ||
| 2021-09-01 | Bohen Sean PRESIDENT AND CEO | Option exercise | +871 | $4.82 | $4K | 55,145 |
| 2021-09-01 | Bohen Sean PRESIDENT AND CEO | Sale | −871 | $30.05 | $26K | 54,274 |
| 2021-09-01 | Bohen Sean PRESIDENT AND CEO | Option exercise · Stock Option (Right to Buy) | −871 | 975,445 | ||
| 2021-08-19 | Harmon Cyrus CHIEF TECHNOLOGY OFFICER | Sale | −12,000 | $24.97 | $300K | 1,075,546 |
| 2021-08-10 | Horn Kinney CHIEF BUSINESS OFFICER | Option exercise | +5,251 | $2.06 | $11K | 7,041 |
| 2021-08-10 | Horn Kinney CHIEF BUSINESS OFFICER | Sale | −5,191 | $25.70 | $133K | 1,850 |
| 2021-08-10 | Horn Kinney CHIEF BUSINESS OFFICER | Sale | −60 | $26.17 | $2K | 1,790 |
| 2021-08-10 | Horn Kinney CHIEF BUSINESS OFFICER | Option exercise · Stock Option (Right to Buy) | −5,251 | 178,544 | ||
| 2021-07-20 | Harmon Cyrus CHIEF TECHNOLOGY OFFICER | Sale | −4,123 | $25.63 | $106K | 1,087,546 |
Page 17 of 21 · 402 trades